Displaying 13 - 24 of 90
Metabolism, Alcohol & Toxicity

Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Approaching MASH as a metabolic disease with the need for holistic therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel Discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and Closing remarks

Webcasts
View
Liver Tumours

Introduction

Webcasts
View
Liver Tumours

General Overview on liver imaging, when do we need MRI? Benefits of liver-specific agents

Webcasts
View
Liver Tumours

Imaging of HCC, results of the SORAMIC trial and treatment stratification in HCC

Webcasts
View
Liver Tumours

Q&A

Webcasts
View
Liver Tumours

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver ...

Webcasts
View
Liver Tumours

Clinical impact of non-arterial enhancing lesions in patients at risk of HCC - therapy and follow-up

Webcasts
View
Metabolism, Alcohol & Toxicity
Wrap-up

Wrap-up

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Displaying 13 - 24 of 90